The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Women in Clinical Trials of New Drugs -- A Change in Food and Drug Administration Policy
Abstract
The Food and Drug Administration (FDA) is taking two important steps to ensure that new drugs are properly evaluated in women. First, it is providing formal guidance to drug developers to emphasize its expectations that women will be appropriately represented in clinical studies and that new drug applications will include analyses capable of identifying potential differences in drug actions or efficacy between the sexes. Second, the agency is altering a 16-year-old policy that has excluded most women with "childbearing potential" from the earliest phases of clinical trials. Attention to sex differences is part of a larger effort by the FDA to ensure that the safety and efficacy of drugs are adequately studied in the full range of patients who will receive therapy and that information is obtained that will allow physicians to individualize therapy. These actions are also being taken in response to questions about whether this country's drug-development process produces adequate information about the effects of drugs in women, as well as more general issues concerning women's health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frezza, M., di Padova, C., Pozzato, G., Terpin, M., Baraona, E., & Lieber, C. S. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001113220205 · Cited by 1,328
Alterations in Glucose Metabolism During Menstrual Cycle in Women With IDDM
Widom, B., Diamond, M. P., & Simonson, D. C. (1992) · Diabetes Care · doi:10.2337/diacare.15.2.213 · Cited by 87
Cited by
What Makes Clinical Research Ethical?
Emanuel, E. J. (2000) · JAMA · doi:10.1001/jama.283.20.2701 · Cited by 2,710
Registries for Evaluating Patient Outcomes: A User’s Guide
(2020) · doi:10.23970/ahrqepcregistries4 · Cited by 960
ROOF, R. L., & HALL, E. D. (2000) · Journal of Neurotrauma · doi:10.1089/neu.2000.17.367 · Cited by 655
Sex differences in animal models of psychiatric disorders
Kokras, N., & Dalla, C. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12710 · Cited by 425
Brain damage, sex hormones and recovery: a new role for progesterone and estrogen?
Stein, D. G. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01821-x · Cited by 340
Metadata
- Authors
- Merkatz, R. B., Temple, R., Sobel, S., Feiden, K., & Kessler, D. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1993-07-22
- Volume
- 329
- Issue
- 4
- Pages
- 292-296
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2328661576
- Cited by
- 234
- References
- 2
- FWCI
- 16.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Women in Clinical Trials of New Drugs -- A Change in Food and Drug Administration Policy. https://app.cochat.ai/papers/10.1056/nejm199307223290429
- The paper
- Merkatz, R. B., Temple, R., Sobel, S., Feiden, K., & Kessler, D. A. (1993). Women in Clinical Trials of New Drugs -- A Change in Food and Drug Administration Policy. New England Journal of Medicine. https://doi.org/10.1056/nejm199307223290429
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.